### Comment:
After further research, all of the people who needed the drug (less than 1,000) have insurance, none of which lost coverage or access to the drug. 
  
 Martin then went on to reinvest the money back into research. The drug turned out to be very unstable and he was raised the price to fund the creation of a safer alternative.

### REPLY:
Do you have a source for this? I just spent 30 minutes looking for one but couldn't find one. 
  
 I remember hearing that people didn't actually end up paying more for the drug, the insurance companies did. I still can't find an article or anything about that.

### END.